Veristat Resource Library
Podcast
Real-world Considerations When Administering Advanced Therapy ProductsListen as Rachel Smith discusses Convection Enhanced Delivery (CED) which delivers medicines ...
Podcast
Planning the Way Forward in Neurodegenerative Disease StudiesListen as Ewan Campbell, Advanced Therapy and Biotech Director for Veristat outlines some of the ...
Podcast
Opportunities for Virtual and Central Site Models in Cell and Gene ...Listen as we replay some of Rachel Smith’s insights from our recent webinar where Rachel reviews ...
Podcast
An Introduction to Natural History StudiesLearn how natural history studies provide evidence for identifying patient subgroups that may ...
Podcast
Common pitfalls to avoid when planning a marketing application for ...Developing a successful marketing application involves several strategic steps, as described by ...
Podcast
Are Autologous Therapies Here to Stay? Are Allogeneic Therapies the ...The pros, cons and future of allogeneic versus autologous therapies are explored as Rachel Smith, ...
Podcast
EU Post Marketing Requirements for Cell and Gene Therapy StudiesPost-marketing requirements within the European submission process offer conditional approval more ...
Podcast
Selecting Endpoints for an Early Phase Cell or Gene StudyThe selection of endpoints for a clinical trial relies on clinical relevance combined with ...
Podcast
Common Pitfalls in Cell Therapy StudiesListen as Kevin Hennegan, Senior Regulatory Strategist for Veristat, shares some of the common ...